Veriton Pharma Pty Limited

Regulatory activities for this sponsor.

2 result(s) found, displaying 1 to 2

AusPAR: Zyamis

20 April 2023

Australian Public Assessment Report (AusPAR)

Zyamis midazolam maleate for the treatment of Generalised Convulsive Status Epilepticus (GCSE).
ZYAMIS (Veriton Pharma Pty Limited)

17 September 2021

Prescription medicine registration

Active ingredients: midazolam maleate.